SYT1 and Cognitive impairment: Finally, Ohrfelt et al. (2016) demonstrate that, in cerebrospinal fluid, SYT1 levels are significantly higher in patients with dementia or mild cognitive impairment due to Alzheimer’s disease compared to controls.